Total Clarity Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,322
Closed -$231K – 388
2026
Q1
$231K Buy
2,322
+112
+5% +$14.6K 0.05% 283
2025
Q4
$269K Sell
2,210
-113
-5% -$14.2K 0.07% 252
2025
Q3
$261K Sell
2,323
-556
-19% -$65.1K 0.07% 239
2025
Q2
$386K Buy
+2,879
New +$316K 0.11% 189
2024
Q4
– Sell
-2,492
Closed -$391K – 293
2024
Q3
$391K Buy
2,492
+277
+13% +$42.7K 0.13% 165
2024
Q2
$334K Buy
+2,215
New +$266K 0.12% 176
2022
Q3
– Sell
-334
Closed -$11K – 910
2022
Q2
$11K Buy
+334
New +$8.91K 0.01% 649
2021
Q2
– Sell
-644
Closed -$27K – 690
2021
Q1
$27K Buy
+644
New +$19.8K 0.02% 423

Other funds holding TMDX

Total Clarity Wealth Management's TMDX Position: Q2 2026 in Review

Total Clarity Wealth Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,322 shares — an estimated $231K sold.

Total Clarity Wealth Management first reported a position in TMDX in Q1 2021 and held it in 8 quarters. The position peaked at $391K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Total Clarity Wealth Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Total Clarity Wealth Management sold 2,322 Transmedics shares in Q2 2026, an estimated $231K.
  • Total Clarity Wealth Management first reported a position in Transmedics in Q1 2021 and held it in 8 quarters.
  • Total Clarity Wealth Management's Transmedics position peaked at $391K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.